60 results on '"Urbańska, E."'
Search Results
2. Quinolinate-like neurotoxicity produced by aminooxyacetic acid in rat striatum
3. P46.03 Targeting ROS1 Gene Rearrangement by Crizotinib as Neoadjuvant Treatment Before Definitive Radiotherapy in Locally Advanced NSCLC
4. P46.02 Impact of Real-World DNA- and RNA-Based Rebiopsy Testing in EGFR-Mutated NSCLC Progressing on Osimertinib
5. P10.06 Affiliation to the Labour Market in Denmark for Patients Under 60 Years of Age After Diagnosis and Treatment for ALK-Positive NSCLC
6. P76.16 EGFR-L858R NSCLC with Pleiotropic Resistance Mechanisms: T790M, C797S, SCLC-Transformation and KRAS, TP53, and BRAF Mutations.
7. EP1.08-07 Correlation Between Genetic Profiling and Response in Danish ALK-Positive NSCLC Patients Treated with Crizotinib
8. P3.08-18 Changing Resistance Mechanisms in Rebiopsies of ALK-Positive NSCLC During Multiple Lines of Therapy: ALK/BRAF-Mutations Followed By EMT
9. P3.01-007 Heterogeneous Resistance Mechanisms in Rebiopsies from EGFR-Mutated NSCLC: Transformation to SCLC; FGFR3 and T790M Mutations
10. Classification and Distortion in Six-Coordinate Bis(salicylaldiminato)nickel(II) Complexes: Crystal Structure of Bis[2-[[(2-hydroxyphenyl)methylene]amino]-1-phenyl-1,3-propanediolato]nickel(II).2H2O
11. Serum interleukin-6 in early diagnosis of infection in NICU neonates
12. 109. Enhanced kynurenic acid levels and cytokine-induced production of 3-hydroxykynurenine in fibroblasts from bipolar or schizophrenic patients
13. NG-nitro-L-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice
14. Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures
15. Serum kynurenic acid positively correlates with cardiovascular disease risk factor, homocysteine: a study in stroke patients
16. Previous prolonged clonic seizures diminish antiepileptic activity of valproate against pentetrazol-evoked convulsions
17. Postcardiotomy delirium in patients after coronary artery bypass graft surgery,Pooperacyjne zaburzenia świadomości u pacjentów poddanych pomostowaniu aortalno-wieńcowemu
18. The evaluation of prevalence of depression among patients undergoing palliative chemotherapy in lung cancer,Ocena wystȩpowania depresji wśród pacjentów poddanych chemioterapii paliatywnej z powodu raka płuc
19. Application of cerebral oximetry in adult cardiovascular surgery - Management protocol,Monitorowanie regionalnej saturacji mózgowej podczas zabiegów kardiochirurgicznych - algorytm postȩpowania
20. Hyperglycemia enhances the inhibitory effect of mitochondrial toxins and D,L-homocysteine on the brain production of kynurenic acid
21. POL-PAVTI - Polish report on transcatheter pulmonary artery valve implantation of Melody-Medtronic prosthesis in the first 14 patients in Poland,Ogólnopolski raport POL-PAVTI z nieoperacyjnego wszczepienia biologicznej zastawki płucnej Melody-Medtronic u pierwszych w Polsce 14 chorych
22. Goal directed therapy - Prevention of the complications in the early postoperative period,Terapia ukierunkowana na cel - profilaktyka powikła? wczesnego okresu pooperacyjnego - podsumowanie kursu
23. The kynurenic acid hypothesis - a new look at etiopathogenesis and treatment of schizophrenia,Koncepcja kynureninowa – nowe spojrzenie na etiopatogenezę i leczenie schizofrenii
24. Cardiac surgery in dialysis-patients with end-stage renal failure,Operacje kardiochirurgiczne u pacjentów dializowanych z powodu skrajnej niewydolności nerek
25. Clenbuterol enhances the production of kynurenic acid in brain cortical slices and glial cultures
26. Effect of pesticides on kynurenic acid production in rat brain slices
27. Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures
28. Glycinergic mechanisms in the toxicity of valproate in mice
29. Effects of Fenofibrate and Gemfibrozil on Kynurenic Acid Production in Rat Kidneys In Vitro: Old Drugs, New Properties.
30. Differences in the dynamics of changes in the concentration of kynurenic acid in the blood serum of depressed patients treated with electroconvulsive therapy.
31. Blood serum concentrations of kynurenic acid in patients diagnosed with recurrent depressive disorder, depression in bipolar disorder, and schizoaffective disorder treated with electroconvulsive therapy.
32. Perioperative care in elderly cardiac surgery patients.
33. [Cardiac surgery in dialysis-patients with end-stage renal failure].
34. [Evaluation of some clinic data in patients with tinea versicolor].
35. [POL-PAVTI--Polish report on transcatheter pulmonary artery valve implantation of Melody-Medtronic prosthesis in the first 14 patients in Poland].
36. Exhaled nitric oxide concentration in patients after heart transplantation.
37. [Newborn life threatening respiratory failure treatment with extracorporeal membrane oxygenation].
38. N(G)-nitro-L-arginine and its methyl ester inhibit brain synthesis of kynurenic acid possibly via nitric oxide-independent mechanism.
39. Protective effect of adenosine receptor agonists in a new model of epilepsy--seizures evoked by mitochondrial toxin, 3-nitropropionic acid, in mice.
40. Effect of adenosine receptor agonists on neurodegenerative and convulsive activity of mitochondrial toxin, 3-nitropropionic acid.
41. Previous prolonged clonic seizures diminish antiepileptic activity of valproate against pentetrazol-evoked convulsions.
42. Formation of endogenous glutamatergic receptors antagonist kynurenic acid--differences between cortical and spinal cord slices.
43. Anticonvulsant action of chlormethiazole is prevented by subconvulsive amounts of strychnine and aminophylline but not by bicuculline and picrotoxin.
44. Seizures evoked by mitochondrial toxin, 3-nitropropionic acid: new mechanism of epileptogenesis?
45. Influence of prolonged clonic seizures in mice upon their susceptibility to chemical convulsants 2 weeks later.
46. Anticonvulsive properties of chlormethiazole in mice.
47. Immune response and epilepsy.
48. Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases.
49. Differential expression of the astrocytic enzymes 3-hydroxyanthranilic acid oxygenase, kynurenine aminotransferase and glutamine synthetase in seizure-prone and non-epileptic mice.
50. Increased brain quinolinic acid production in mice infected with a hamster neurotropic measles virus.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.